Related Experiment Video
Updated: Jul 7, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Models for non-alcoholic fatty liver disease: a link with vascular risk
E Xirouchakis1, A Sigalas, P Manousou
1The Sheila Sherlock Hepatobiliary Pancreatic and Liver Transplantation Unit, Royal Free Hospital, London, UK.
Abstract:
Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
